- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06177548
Safety and Efficacy of the Minimally Invasive Bentall Procedure Via a Small Right Intercostal Incision in Patients With Aortic Root Lesions (Mini-Bentall)
July 10, 2024 updated by: First Affiliated Hospital Xi'an Jiaotong University
Safety and Efficacy of the Minimally Invasive Bentall Procedure Via a Small Right Intercostal Incision in Patients With Aortic Root Lesions: an Investigator-initiated, Single-center, Retrospective Cohort Study
This study intends to include patients who had aortic root lesions and were treated with Bentall surgery from January 2019 to July 2023 in the First Affiliated Hospital of Xi'an Jiaotong University.
The patients will be divided into the minimally invasive group and control group according to the surgical methods: the former underwent minimally invasive Bentall surgery through a small right intercostal incision; the latter underwent traditional Bentall surgery through a median sternal incision.
By comparing the clinical data of patients in two groups, we will investigate the effect and safety of minimally invasive Bentall surgery.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
350
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Li Guoliang
- Phone Number: +86.29.85323869
- Email: liguoliang_med@163.com
Study Contact Backup
- Name: Yan Yang
- Phone Number: +86.29.85323869
- Email: yangyan3@xjtu.edu.cn
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710061
- Recruiting
- First Affiliated Hospital of Xi'an Jiantong University
-
Contact:
- Guoliang Li
- Phone Number: 008613759982523
- Email: liguoliang_med@163.com
-
Contact:
- Yang Yan
- Phone Number: +86.29.85323869
- Email: yangyan3@xjtu.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients who were diagnosed with aortic root lesions and treated with the Bentall procedure at the First Affiliated Hospital of Xi'an Jiaotong University from January 2019 to July 2023 will be included in this study.
Description
Inclusion Criteria:
- Patients who were diagnosed with aortic root lesions and treated with the Bentall procedure at the First Affiliated Hospital of Xi'an Jiaotong University from January 2019 to July 2023 will be included in this study.
Exclusion Criteria:
- Previous sternotomy or aortic root surgery;
- Combined coronary artery disease requiring simultaneous coronary revascularization;
- Combined aortic arch lesions requiring simultaneous aortic arch surgery;
- Preoperative comorbidities with severe single or multiple organ failure;
- Incomplete clinical information;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Minimally invasive Group
Patients who underwent minimally invasive Bentall procedure will be included.
The minimally invasive Bentall procedure is performed through a small incision in the right intercostal space.
|
The minimally invasive Bentall procedure is performed through a small incision in the right intercostal space.
|
|
Control Group
Patient who underwent Bentall procedure through median sternotomy will be included.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
30-day mortality rate
Time Frame: 1-month after the operation.
|
It focuses on the mortality rate of all patients after the operation after 30 days.
The data will be obtained from medical records.
|
1-month after the operation.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative ventilation time
Time Frame: About 1 day after the operation.
|
It focuses on the postoperative ventilation time of all patients after the operation.
The data will be obtained from medical records.
|
About 1 day after the operation.
|
|
Mortality rate during hospitalization
Time Frame: About 10 days after the operation.
|
It focuses on the mortality rate of all patients after the operation during hospitalization.
The data will be obtained from medical records.
|
About 10 days after the operation.
|
|
Blood transfusion volume during hospitalization
Time Frame: About 10 days after the operation.
|
It focuses on the blood transfusion volumes of all patients after the operation during hospitalization.
The data will be obtained from medical records.
|
About 10 days after the operation.
|
|
Postoperative ICU length of stay
Time Frame: About 3 days after the operation.
|
It focuses on the ICU length of stay of all patients after the operation.
The data will be obtained from medical records.
|
About 3 days after the operation.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yang Yan, First Affiliated Hospital Xi'an Jiaotong University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 11, 2023
Primary Completion (Estimated)
October 25, 2024
Study Completion (Estimated)
December 28, 2024
Study Registration Dates
First Submitted
December 11, 2023
First Submitted That Met QC Criteria
December 11, 2023
First Posted (Actual)
December 20, 2023
Study Record Updates
Last Update Posted (Actual)
July 12, 2024
Last Update Submitted That Met QC Criteria
July 10, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XJTU1AF2023LSK-434
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Dissection
-
First Affiliated Hospital of Zhejiang UniversityNot yet recruitingAortic Dissection Involving the Descending Thoracic Aorta | Aortic Dissection Rupture | Aortic Dissection AneurysmChina
-
Ruijin HospitalRecruitingAscending Aortic DissectionChina
-
Centre Cardiologique du NordUniversita degli Studi di Genova; Campus Bio-Medico University; Henri Mondor... and other collaboratorsEnrolling by invitationAortic Valve Insufficiency | Type B Aortic Dissection | Aortic Diseases | Ascending Aortic Dissection | Aortic Arch | Aortic Root Dissection | Aortic Root Dilatation | Type A Aortic DissectionFrance
-
W.L.Gore & AssociatesRecruitingAortic Arch Aneurysm | Aortic Arch DissectionUnited States
-
Artivion Inc.Bright Research PartnersRecruitingAortic Arch Aneurysm | Acute Aortic Dissection | Aortic Arch Dissection | Chronic Aortic DissectionUnited States
-
Qingyou MengActive, not recruitingThoracic Aortic Dissection | Thoracic Aortic DiseaseChina
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingAortic Aneurysm | Aortic Aneurysm and DissectionItaly
-
Baylor Research InstituteMedtronicTerminatedDissection of Thoracic AortaUnited States
-
Shanghai Zhongshan HospitalActive, not recruiting
-
Assiut UniversityCompletedAortic Root Aneurysm | Aortic Root DissectionEgypt
Clinical Trials on Minimally invasive Bentall procedure
-
University of California, San DiegoCompleted
-
University of Turin, ItalyCompleted
-
Virginia Commonwealth UniversityTerminatedAtrial FibrillationUnited States
-
University of FloridaCompletedStroke | Atrial FibrillationUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Northwell HealthPediatric Surgical Research CollaborativeActive, not recruitingPilonidal Disease | Pilonidal Sinus Without Abscess | Pilonidal Cyst/Fistula | Pilonidal Cyst Without Abscess | Pilonidal Cyst and Sinus Without Abscess | Pilonidal Abscess | Pilonidal Sinus With Abscess | Pilonidal Dimple With Abscess | Pilonidal Fistula With Abscess | Pilonidal Sinus Infected | Pilonidal... and other conditionsUnited States
-
Chang Gung Memorial HospitalCompletedBreast Reconstruction | Mastectomy; LymphedemaTaiwan
-
Cardiopulmonary Research Science and Technology...Virginia Commonwealth University; AtriCure, Inc.CompletedAtrial Fibrillation AblationUnited States
-
St. Paul's Hospital, CanadaStryker NordicNot yet recruitingHallux Valgus and BunionCanada
-
The Griffin InstituteMedtronic; Wellcome/EPSRC for Interventional and Surgical Sciences (WEISS)RecruitingRectal Cancer | Prostate CancerUnited Kingdom